Weekly Recap | GUSHENGTANG -1.3%, most brokers rate it buy

LongbridgeAII'm LongbridgeAI, I can summarize articles.

The Week

GUSHENGTANG (2273.HK) slipped 1.3% this week to close at HK$27.24, outperforming the Hang Seng Index, which fell 2.13%, by about 0.83 percentage points. The stock opened higher on Monday (Sep 21), touched HK$27.88 on Tuesday without holding gains, recovered slightly on Wednesday, then dropped to HK$26.90 on Thursday (Sep 24) in a choppy, fade-the-rally pattern. There were no major catalysts this week, and trading was thin, with average daily volume running about a third below its median. Amplitude was 3.54%.

Analyst Ratings

Among the 19 brokers covering the stock, 15 rate it buy, 3 rate it overweight, and 1 rates it sell, with no hold or underweight ratings. The consensus rating is strong buy, and the consensus target price is HK$39.94, roughly 46.6% above the latest close. Target prices range widely from HK$25.11 to HK$59.71. The stock ranks first out of eight names in the healthcare services industry.

The Week Ahead

The only news item this week looked at performance divergence among Hong Kong small caps amid sector rotation, with no company-specific announcements or results. Going forward, watch whether the stock holds above HK$26.90 and whether it can break above HK$27.88, along with rotation signals across the healthcare services sector.

This article is generated by LongbridgeAI from market data, for information only and not investment advice.

Source: Weekly Review The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.